Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study
- PMID: 19474461
- DOI: 10.1177/1087054708325118
Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study
Abstract
Objective: To compare the morning and afternoon/evening functioning of children with ADHD treated in the community with either atomoxetine or long-acting stimulants and reported to be doing well.
Method: 109 8- to 12-year-olds and their mothers participated in one of three groups: stimulants (STIM, N = 26), atomoxetine (ATMX, N = 25), or comparison (COMP, N = 58). Mothers completed morning and evening electronic diaries installed on personal digital assistants throughout an entire week, rating the child's behaviors and moods as well as their own moods and perceptions.
Results: There was no evidence that ongoing pharmacotherapy fully normalized the behaviors of children with ADHD: Mothers in both ADHD groups reported higher rates of child inattention, hyperactivity/impulsivity, oppositionality, and negative affect and lower levels of parenting efficacy and positive affect than did COMP mothers. Although the behavioral profiles were generally comparable for the STIM and ATMX groups, there were indications of better functioning in the ATMX group during mornings only.
Conclusion: Children treated in the community with either STIM or ATMX appear to have similar behavioral profiles, suggesting that medication decisions be guided by other factors such as comorbid disorders, child and parent preferences, and effects on nontargeted behaviors and moods.
Similar articles
-
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2015 Sep;25(7):566-73. doi: 10.1089/cap.2015.0035. Epub 2015 Jul 29. J Child Adolesc Psychopharmacol. 2015. PMID: 26222447 Clinical Trial.
-
How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.J Atten Disord. 2012 May;16(4):314-24. doi: 10.1177/1087054710389989. Epub 2011 Feb 2. J Atten Disord. 2012. PMID: 21289234
-
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017. Clin Ther. 2007. PMID: 17692731 Clinical Trial.
-
Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents.J Child Adolesc Psychopharmacol. 2010 Jun;20(3):197-203. doi: 10.1089/cap.2009.0104. J Child Adolesc Psychopharmacol. 2010. PMID: 20578932
-
Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.Ann Pharmacother. 2006 Jun;40(6):1134-42. doi: 10.1345/aph.1G582. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735655 Review.
Cited by
-
Change in Adolescents' Perceived ADHD Symptoms Across 17 Days of Ecological Momentary Assessment.J Clin Child Adolesc Psychol. 2024 May-Jun;53(3):397-412. doi: 10.1080/15374416.2022.2096043. Epub 2022 Jul 26. J Clin Child Adolesc Psychol. 2024. PMID: 35882042 Free PMC article.
-
Advances in understanding and treating ADHD.BMC Med. 2011 Jun 10;9:72. doi: 10.1186/1741-7015-9-72. BMC Med. 2011. PMID: 21658285 Free PMC article. Review.
-
Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.J Child Adolesc Psychopharmacol. 2017 Oct;27(8):715-722. doi: 10.1089/cap.2016.0164. Epub 2017 Apr 10. J Child Adolesc Psychopharmacol. 2017. PMID: 28394175 Free PMC article.
-
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.CNS Drugs. 2015 Feb;29(2):131-51. doi: 10.1007/s40263-014-0224-9. CNS Drugs. 2015. PMID: 25698145 Review.
-
Modeling nonlinear time-dependent treatment effects: an application of the generalized time-varying effect model (TVEM).J Consult Clin Psychol. 2014 Oct;82(5):760-72. doi: 10.1037/a0035267. Epub 2013 Dec 23. J Consult Clin Psychol. 2014. PMID: 24364799 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous